chr16-1210449-G-A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_021098.3(CACNA1H):​c.3925G>A​(p.Val1309Ile) variant causes a missense change. The variant allele was found at a frequency of 0.000549 in 1,611,380 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V1309F) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.00034 ( 0 hom., cov: 27)
Exomes 𝑓: 0.00057 ( 0 hom. )

Consequence

CACNA1H
NM_021098.3 missense

Scores

3
16

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 4.33

Publications

4 publications found
Variant links:
Genes affected
CACNA1H (HGNC:1395): (calcium voltage-gated channel subunit alpha1 H) This gene encodes a T-type member of the alpha-1 subunit family, a protein in the voltage-dependent calcium channel complex. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization and consist of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. The alpha-1 subunit has 24 transmembrane segments and forms the pore through which ions pass into the cell. There are multiple isoforms of each of the proteins in the complex, either encoded by different genes or the result of alternative splicing of transcripts. Alternate transcriptional splice variants, encoding different isoforms, have been characterized for the gene described here. Studies suggest certain mutations in this gene lead to childhood absence epilepsy (CAE). [provided by RefSeq, Jul 2008]
CACNA1H Gene-Disease associations (from GenCC):
  • hyperaldosteronism, familial, type IV
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • childhood absence epilepsy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • epilepsy, childhood absence, susceptibility to, 6
    Inheritance: AD Classification: LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.030431986).
BP6
Variant 16-1210449-G-A is Benign according to our data. Variant chr16-1210449-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 570660.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.000343 (52/151532) while in subpopulation NFE AF = 0.000633 (43/67910). AF 95% confidence interval is 0.000482. There are 0 homozygotes in GnomAd4. There are 24 alleles in the male GnomAd4 subpopulation. Median coverage is 27. This position passed quality control check.
BS2
High AC in GnomAd4 at 52 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CACNA1HNM_021098.3 linkc.3925G>A p.Val1309Ile missense_variant Exon 19 of 35 ENST00000348261.11 NP_066921.2 O95180-1B3KQH9

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CACNA1HENST00000348261.11 linkc.3925G>A p.Val1309Ile missense_variant Exon 19 of 35 1 NM_021098.3 ENSP00000334198.7 O95180-1
CACNA1HENST00000569107.6 linkc.3925G>A p.Val1309Ile missense_variant Exon 19 of 34 1 ENSP00000454990.2 H3BNT0
CACNA1HENST00000711493.1 linkc.3925G>A p.Val1309Ile missense_variant Exon 19 of 34 ENSP00000518778.1
CACNA1HENST00000565831.7 linkc.3925G>A p.Val1309Ile missense_variant Exon 19 of 34 1 ENSP00000455840.1 O95180-2
CACNA1HENST00000711450.1 linkc.3925G>A p.Val1309Ile missense_variant Exon 19 of 35 ENSP00000518762.1
CACNA1HENST00000564231.6 linkc.3925G>A p.Val1309Ile missense_variant Exon 19 of 35 1 ENSP00000457555.2 H3BUA8
CACNA1HENST00000638323.1 linkc.3886G>A p.Val1296Ile missense_variant Exon 19 of 35 5 ENSP00000492267.1 A0A1W2PR14
CACNA1HENST00000562079.6 linkc.3925G>A p.Val1309Ile missense_variant Exon 19 of 34 1 ENSP00000454581.2 H3BMW6
CACNA1HENST00000711438.1 linkc.3886G>A p.Val1296Ile missense_variant Exon 19 of 34 ENSP00000518754.1
CACNA1HENST00000711482.1 linkc.3925G>A p.Val1309Ile missense_variant Exon 19 of 36 ENSP00000518771.1
CACNA1HENST00000711485.1 linkc.3925G>A p.Val1309Ile missense_variant Exon 19 of 35 ENSP00000518774.1
CACNA1HENST00000711455.1 linkc.3925G>A p.Val1309Ile missense_variant Exon 19 of 36 ENSP00000518768.1
CACNA1HENST00000711483.1 linkc.3925G>A p.Val1309Ile missense_variant Exon 19 of 35 ENSP00000518772.1
CACNA1HENST00000711456.1 linkc.3925G>A p.Val1309Ile missense_variant Exon 19 of 34 ENSP00000518769.1
CACNA1HENST00000621827.2 linkn.3925G>A non_coding_transcript_exon_variant Exon 19 of 37 6 ENSP00000518766.1
CACNA1HENST00000637236.3 linkn.3975G>A non_coding_transcript_exon_variant Exon 19 of 34 5 ENSP00000492650.2 A0A1W2PS38
CACNA1HENST00000639478.1 linkn.3925G>A non_coding_transcript_exon_variant Exon 19 of 35 5 ENSP00000491945.1 A0A1W2PQW2
CACNA1HENST00000640028.1 linkn.*1838G>A non_coding_transcript_exon_variant Exon 19 of 35 5 ENSP00000491488.1 A0A1W2PQ19
CACNA1HENST00000711442.1 linkn.*3372G>A non_coding_transcript_exon_variant Exon 18 of 34 ENSP00000518758.1
CACNA1HENST00000711448.1 linkn.3925G>A non_coding_transcript_exon_variant Exon 19 of 36 ENSP00000518760.1
CACNA1HENST00000711449.1 linkn.3925G>A non_coding_transcript_exon_variant Exon 19 of 35 ENSP00000518761.1
CACNA1HENST00000711451.1 linkn.3925G>A non_coding_transcript_exon_variant Exon 19 of 36 ENSP00000518763.1
CACNA1HENST00000711452.1 linkn.3925G>A non_coding_transcript_exon_variant Exon 19 of 36 ENSP00000518764.1
CACNA1HENST00000711453.1 linkn.3925G>A non_coding_transcript_exon_variant Exon 19 of 36 ENSP00000518765.1
CACNA1HENST00000711484.1 linkn.3925G>A non_coding_transcript_exon_variant Exon 19 of 35 ENSP00000518773.1
CACNA1HENST00000711486.1 linkn.3925G>A non_coding_transcript_exon_variant Exon 19 of 37 ENSP00000518775.1
CACNA1HENST00000711487.1 linkn.3925G>A non_coding_transcript_exon_variant Exon 19 of 36 ENSP00000518776.1
CACNA1HENST00000711488.1 linkn.3925G>A non_coding_transcript_exon_variant Exon 19 of 35 ENSP00000518777.1
CACNA1HENST00000640028.1 linkn.*1838G>A 3_prime_UTR_variant Exon 19 of 35 5 ENSP00000491488.1 A0A1W2PQ19
CACNA1HENST00000711442.1 linkn.*3372G>A 3_prime_UTR_variant Exon 18 of 34 ENSP00000518758.1

Frequencies

GnomAD3 genomes
AF:
0.000343
AC:
52
AN:
151532
Hom.:
0
Cov.:
27
show subpopulations
Gnomad AFR
AF:
0.0000485
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000658
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000286
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000633
Gnomad OTH
AF:
0.00144
GnomAD2 exomes
AF:
0.000461
AC:
114
AN:
247246
AF XY:
0.000490
show subpopulations
Gnomad AFR exome
AF:
0.0000651
Gnomad AMR exome
AF:
0.0000291
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000804
Gnomad NFE exome
AF:
0.000805
Gnomad OTH exome
AF:
0.000833
GnomAD4 exome
AF:
0.000571
AC:
833
AN:
1459848
Hom.:
0
Cov.:
38
AF XY:
0.000580
AC XY:
421
AN XY:
726260
show subpopulations
African (AFR)
AF:
0.0000896
AC:
3
AN:
33466
American (AMR)
AF:
0.0000672
AC:
3
AN:
44676
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26124
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39682
South Asian (SAS)
AF:
0.0000232
AC:
2
AN:
86214
European-Finnish (FIN)
AF:
0.000886
AC:
46
AN:
51916
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5768
European-Non Finnish (NFE)
AF:
0.000683
AC:
759
AN:
1111662
Other (OTH)
AF:
0.000315
AC:
19
AN:
60340
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.462
Heterozygous variant carriers
0
45
90
135
180
225
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
30
60
90
120
150
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000343
AC:
52
AN:
151532
Hom.:
0
Cov.:
27
AF XY:
0.000325
AC XY:
24
AN XY:
73908
show subpopulations
African (AFR)
AF:
0.0000485
AC:
2
AN:
41220
American (AMR)
AF:
0.0000658
AC:
1
AN:
15196
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5146
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4782
European-Finnish (FIN)
AF:
0.000286
AC:
3
AN:
10496
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.000633
AC:
43
AN:
67910
Other (OTH)
AF:
0.00144
AC:
3
AN:
2086
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.487
Heterozygous variant carriers
0
4
7
11
14
18
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000435
Hom.:
0
Bravo
AF:
0.000272
TwinsUK
AF:
0.000809
AC:
3
ALSPAC
AF:
0.00
AC:
0
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000117
AC:
1
ExAC
AF:
0.000421
AC:
51
EpiCase
AF:
0.000436
EpiControl
AF:
0.000474

ClinVar

Significance: Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

CACNA1H-related disorder Benign:1
May 12, 2024
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Epilepsy, childhood absence, susceptibility to, 6;C4310756:Hyperaldosteronism, familial, type IV Benign:1
Dec 10, 2021
Fulgent Genetics, Fulgent Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Idiopathic generalized epilepsy;C4310756:Hyperaldosteronism, familial, type IV Benign:1
Nov 23, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.054
BayesDel_addAF
Benign
-0.26
T
BayesDel_noAF
Benign
-0.22
CADD
Benign
13
DANN
Benign
0.92
DEOGEN2
Benign
0.39
T;.;.;.
Eigen
Benign
-0.93
Eigen_PC
Benign
-0.67
FATHMM_MKL
Benign
0.33
N
LIST_S2
Benign
0.83
T;T;T;.
M_CAP
Uncertain
0.22
D
MetaRNN
Benign
0.030
T;T;T;T
MetaSVM
Uncertain
-0.26
T
MutationAssessor
Benign
-2.6
N;.;N;N
PhyloP100
4.3
PrimateAI
Benign
0.44
T
PROVEAN
Benign
0.84
N;.;N;N
REVEL
Uncertain
0.30
Sift
Benign
1.0
T;.;T;T
Sift4G
Benign
1.0
T;.;T;T
Polyphen
0.0010
B;.;B;B
Vest4
0.12
MVP
0.53
ClinPred
0.012
T
GERP RS
2.7
PromoterAI
-0.21
Neutral
Varity_R
0.052
gMVP
0.31
Mutation Taster
=88/12
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs201352768; hg19: chr16-1260449; COSMIC: COSV61992106; COSMIC: COSV61992106; API